Soy and the prevention of lifestyle-related diseases

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue SUPPL.2, 2004, Pages

  Zhou, Jin Rong ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Cardiovascular disease; Menopausal symptoms; Soy

Indexed keywords

ANIMAL; BREAST TUMOR; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; LIFESTYLE; MALE; MENOPAUSE; PROSTATE TUMOR; REVIEW; SOYBEAN;

ANIMALS; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIFE STYLE; MALE; MENOPAUSE; PROSTATIC NEOPLASMS; SOY FOODS;

EID: 39749160479     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.04123.x     Document Type: Article

References (89)

1. American Heart Association. 2002 Heart and Stroke Statistical Update. American Heart Association, Dallas. 2001.
2. Beaglehole R. International trends in coronary heart disease mortality, morbidity, and risk factors. Epidemiol. Rev. 1990; 12: 1-15.
3. Federal Drug Administration. Food labeling, health claims, soy protein, and coronary heart disease. Fed. Regist. 1999; 57: 699.
4. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 1995; 333: 276-82.DOI: 10.1056/NEJM199508033330502
5. Baum JA, Teng H, Erdman Jr JW et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am. J. Clin. Nutr. 1998; 68: 545-51.
6. Crouse 3Rd JR, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch. Intern. Med. 1999; 159: 2070-6.DOI: 10.1001/archinte.159.17.2070
7. Merz-Demlow BE, Duncan AM, Wangen KE et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am. J. Clin. Nutr. 2000; 71: 1462-9.
8. Wangen KE, Duncan AM, Xu X, Kurzer MS. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am. J. Clin. Nutr. 2001; 73: 225-31.
9. Gardner CD, Newell KA, Cherin R, Haskell WL. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am. J. Clin. Nutr. 2001; 73: 728-35.
10. Nestel PJ, Yamashita T, Sasahara T et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 3392-8.
11. Simons LA, Von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am. J. Cardiol. 2000; 85: 1297-301.DOI: 10.1016/S0002-9149(00)00759-1
12. Hsu CS, Shen WW, Hsueh YM, Yeh SL. Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J. Reprod. Med. 2001; 46: 221-6.
13. Dewell A, Hollenbeck CB, Bruce B. The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J. Clin. Endocrinol. Metab. 2002; 87: 118-21.DOI: 10.1210/jc.87.1.118
14. West SG. Blood pressure and vascular effects of soy: How strong is the evidence? Curr. Top. Nutraceut. Res. 2003; 1: 17-30.
15. Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am. J. Clin. Nutr. 2003; 78: 123-30.
16. Messina M, Barnes S. The role of soy products in reducing risk of cancer. J. Natl Cancer Inst. 1991; 83: 541-6.
17. Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr. Cancer 1994; 21: 113-31.
18. Horn-Ross P, Hoggatt K, West D et al. Recent diet and breast cancer risk: The California Teachers Study (USA). Cancer Causes Control 2002; 13: 407-15.DOI: 10.1023/A:1015786030864
19. Key TJ, Sharp GB, Appleby PN et al. Soya foods and breast cancer risk: A prospective study in Hiroshima and Nagasaki, Japan. Br. J. Cancer 1999; 81: 1248-56.DOI: 10.1038/sj.bjc.6690837
20. Nagata C. Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan. Int. J. Epidemiol. 2000; 29: 832-6.DOI: 10.1093/ije/29.5.832
21. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Soy, isoflavones, and breast cancer risk in Japan. J. Natl Cancer Inst. 2003; 95: 906-13.
22. Den Tonkelaar I, Keinan-Boker L, Van't Veer P et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 2001; 10: 223-8.
23. Horn-Ross PL, John EM, Lee M et al. Phytoestrogen consumption and breast cancer risk in a multiethnic population: The Bay Area breast cancer study. Am. J. Epidemiol. 2001; 154: 434-41.DOI: 10.1093/aje/154.5.434
24. Murkies A, Dalais FS, Briganti EM et al. Phytoestrogens and breast cancer in postmenopausal women: A case control study. Menopause 2000; 7: 289-96.
25. Dai Q, Shu XO, Jin F et al. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br. J. Cancer 2001; 85: 372-8.DOI: 10.1054/bjoc.2001.1873
26. Dai Q, Franke A, Jin F et al. Urinary excretion of phytoestrogens and risk of breast cancer among chinese women in Shanghai. Cancer Epidemiol. Biomarkers Prev. 2002; 11: 815-21.
27. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997; 350: 990-4.DOI: 10.1016/S0140-6736(97)01339-1
28. Shu XO, Jin F, Dai Q et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol. Biomarkers Prev. 2001; 10: 483-8.
29. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002; 23: 1491-6.
30. Zheng W, Dai Q, Custer LJ et al. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 1999; 8: 35-40.
31. Appelt LC, Reicks MM. Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats. J. Nutr. 1999; 129: 1820-6.
32. Cohen LA, Zhao Z, Pittman B, Scimeca JA. Effect of intact and isoflavone-depleted soy protein on NMU-induced rat mammary tumorigenesis. Carcinogenesis 2000; 21: 929-35.
33. Constantinou AI, Lantvit D, Hawthorne M, Xu X, Van Breemen RB, Pezzuto JM. Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr. Cancer 2001; 41: 75-81.
34. Gallo D, Giacomelli S, Cantelmo F et al. Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy. Breast Cancer Res. Treat. 2001; 69: 153-64.DOI: 10.1023/A:1012414119944
35. Lamartiniere CA, Wang J, Smith-Johnson M, Eltoum IE. Daidzein: Bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol. Sci. 2002; 65: 228-38.DOI: 10.1093/toxsci/65.2.228
36. Zaizen Y, Higuchi Y, Matsuo N, Shirabe K, Tokuda H, Takeshita M. Antitumor effects of soybean hypocotyls and soybeans on the mammary tumor induction by N-methyl-N-nitrosourea in F344 rats. Anticancer Res. 2000; 20: 1439-44.
37. Hakkak R, Korourian S, Shelnutt SR, Lensing S, Ronis MJ, Badger TM. Diets containing whey proteins or soy protein isolate protect against 7, 12-dimethylbenz(a)anthracene-induced mammary tumors in female rats. Cancer Epidemiol. Biomarkers Prev. 2000; 9: 113-17.
38. Fritz WA, Coward L, Wang J, Lamartiniere CA. Dietary genistein: Perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 1998; 19: 2151-8.
39. Badger TM, Ronis MJ, Hakkak R. Developmental effects and health aspects of soy protein isolate, casein, and whey in male and female rats. Int. J. Toxicol. 2001; 20: 165-74.DOI: 10.1080/109158101317097755
40. Gotoh T, Yamada K, Yin H, Ito A, Kataoka T, Dohi K. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn J. Cancer Res. 1998; 89: 137-42.
41. Ohta T, Nakatsugi S, Watanabe K et al. Inhibitory effects of Bifidobacterium-fermented soy milk on 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones. Carcinogenesis 2000; 21: 937-41.
42. Jin Z, MacDonald RS. Soy isoflavones increase latency of spontaneous mammary tumors in mice. J. Nutr. 2002; 132: 3186-90.
43. Yang X, Edgerton SM, Kosanke SD et al. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res. 2003; 63: 2425-33.
44. Mizunuma H, Kanazawa K, Ogura S, Otsuka S, Nagai H. Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer. Oncology 2002; 62: 78-84.DOI: 10.1159/000048250
45. Yuan L, Wagatsuma C, Yoshida M et al. Inhibition of human breast cancer growth by GCP (genistein combined polysaccharide) in xenogeneic athymic mice: Involvement of genistein biotransformation by beta-glucuronidase from tumor tissues. Mutat. Res. 2003; 523-524: 55-62.
46. Yan L, Li D, Yee JA. Dietary supplementation with isolated soy protein reduces metastasis of mammary carcinoma cells in mice. Clin. Exp. Metastasis 2002; 19: 535-40.
47. Hsieh C-Y, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 1998; 58: 3833-8.
48. Ju YH, Allred CD, Allred KF, Karko KL, Doerge DR, Helferich WG. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr. 2001; 131: 2957-62.
49. Allred CD, Ju YH, Allred KF, Chang J, Helferich WG. Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis 2001; 22: 1667-73.
50. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res. 2001; 61: 5045-50.
51. Zhou J-R, Yu L, Mai Z, Blackburn GL. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int. J. Cancer 2004; 108: 8-14.
52. Shao Z-M, Wu J, Shen Z-Z, Barsky SH. Genistein exerts mutiple suppressive effects on human breast carcinoma cells. Cancer Res. 1998; 58: 4851-7.
53. Brodie A, Lu Q, Nakamura J. Aromatase in the normal breast and breast cancer. J. Steroid Biochem. Mol. Biol. 1997; 61: 281-6.
54. Wang T, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1997; 17: 271-5.
55. So FV, Guthrie N, Chambers AF, Carroll KK. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett. 1997; 112: 127-33.
56. Hebert JR, Hurley TG, Olendzki BC, Teas J, Ma Y, Hampl JS. Nutritional and socioeconomic factors in relation to prostate cancer mortality: A cross-national study. J. Natl Cancer Inst. 1998; 90: 1637-47.
57. Jacobsen BK, Knutsen SF, Fraser GE. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control 1998; 9: 553-7.
58. Kolonel LN, Hankin JH, Whittemore AS et al. Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study. Cancer Epidemiol. Biomarkers Prev. 2000; 9: 795-804.
59. Villeneuve P, Johnson K, Kreiger N, Mao Y. Risk factors for prostate cancer: Results from the Canadian National Enhanced Cancer Surveillance System. Cancer Causes Control 1999; 10: 355-67.
60. Sonoda T, Nagata Y, Mori M et al. A case-control study of diet and prostate cancer in Japan: Possible protective effect of traditional Japanese diet. Cancer Sci. 2004; 95: 238-42.
61. Strom SS, Yamamura Y, Duphorne CM et al. Phytoestrogen intake and prostate cancer: A case-control study using a new database. Nutr. Cancer 1999; 33: 20-5.
62. Akaza H, Miyanaga N, Takashima N et al. Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration. Jpn J. Clin. Oncol. 2002; 32: 296-300.
63. Kato K, Takahashi S, Cui L et al. Suppressive effects of dietary genistin and daidzin on rat prostate carcinogenesis. Jpn J. Cancer Res. 2000; 91: 786-91.
64. Onozawa M, Kawamori T, Baba M et al. Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats. Jpn J. Cancer Res. 1999; 90: 393-8.
65. Pollard M, Wolter W, Sun L. Prevention of induced prostate-related cancer by soy protein isolate/isoflavone-supplemented diet in Lobund-Wistar rats. In Vivo 2000; 14: 389-92.
66. Wang J, Eltoum I, Lamartiniere C. Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats. Cancer Lett. 2002; 186: 11-18.
67. Pollard M, Wolter W. Prevention of spontaneous prostate-related cancer in Lobund-Wistar rats by a soy protein isolate/isoflavone diet. Prostate 2000; 45: 101-5.
68. Pollard M, Wolter W, Sun L. Diet and the duration of testosterone-dependent prostate cancer in Lobund-Wistar rats. Cancer Lett. 2001; 173: 127-31.
69. Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res. 2001; 61: 6777-82.
70. Landstrom M, Zhang J-X, Hallmans G et al. Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate 1998; 36: 151-61.
71. Bylund A, Zhang JX, Bergh A et al. Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate 2000; 42: 304-14.
72. Aronson WJ, Tymchuk CN, Elashoff RM et al. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones. Nutr. Cancer 1999; 35: 130-6.
73. Wan XS, Ware JH, Zhang L et al. Treatment with soybean-derived Bowman Birk inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude mice. Prostate 1999; 41: 243-52.
74. Zhou J-R, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J. Nutr. 1999; 129: 1628-35.
75. Zhou J-R, Yu L, Zhong Y et al. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components. Prostate 2002; 53: 143-53.
76. Zhou J-R, Yu L, Zhong Y, Blackburn GL. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J. Nutr. 2003; 133: 516-21.
77. Writing Group for the Women's Health Initiative Randomized Controlled Trial. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-33.
78. Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and hot flashes in Japanese women: Results from a community-based prospective study. Am. J. Epidemiol. 2001; 153: 790-3.
79. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet. Gynecol. 1998; 91: 6-11.
80. Albertazzi P, Pansini F, Bottazzi M, Bonaccorsi G, De Aloysio D, Morton MS. Dietary soy supplementation and phytoestrogen levels. Obstet. Gynecol. 1999; 94: 229-31.
81. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999; 6: 7-13.
82. Scambia G, Mango D, Signorile PG et al. Clinical effects of a standardized soy extract in postmenopausal women: A pilot study. Menopause 2000; 7: 105-11.
83. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: A multicenter, double-blind, randomized, placebo-controlled study. Menopause 2000; 7: 236-42.
84. Han KK, Soares Jr JM, Haidar MA, De Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet. Gynecol. 2002; 99: 389-94.
85. Quella SK, Loprinzi CL, Barton DL et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J. Clin. Oncol. 2000; 18: 1068-74.
86. Nikander E, Kilkkinen A, Metsa-Heikkila M et al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet. Gynecol. 2003; 101: 1213-20.
87. Van Patten CL, Olivotto IA, Chambers GK et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: A randomized, controlled clinical trial. J. Clin. Oncol. 2002; 20: 1449-55.
88. Huntley AL, Ernst E. Soy for the treatment of perimenopausal symptoms: A systematic review. Maturitas 2004; 47: 1-9.
89. Messina M, Hughes C. Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency. J. Med. Food 2003; 6: 1-11.